Gabelli & Co Investment Advisers’s Aerie Pharmaceuticals AERI Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-230,400	Closed	-$3.49M	–	439
2022 Q3	$3.49M	Buy	+230,400	New	+$2.68M	0.45%	46

Gabelli & Co Investment Advisers's AERI Position: Q4 2022 in Review

Gabelli & Co Investment Advisers sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 230,400 shares — an estimated $3.49M sold.

Gabelli & Co Investment Advisers first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $3.49M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Gabelli & Co Investment Advisers reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 230,400 Aerie Pharmaceuticals shares in Q4 2022, an estimated $3.49M.
Gabelli & Co Investment Advisers first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Aerie Pharmaceuticals position peaked at $3.49M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.